Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BST/BSFA stock hub

BST/BSFA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BST/BSFAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.6B

Stuttgart Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BST/BSFA

In the news

Latest news · BST/BSFA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.3

P25 n/aP50 n/aP75 n/a

Trailing P/E21.6

P25 n/aP50 n/aP75 n/a

ROE18.3

P25 n/aP50 n/aP75 n/a

ROIC8.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BST/BSFA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

USD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	970
Employees Change	255%
Employees Change Percent	39.72
Enterprise value	EUR 1.8B
Exchange	Stuttgart Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 1.6B
Price	EUR 70
Price currency	EUR
Rev Per Employee	825,907.44x
Sic	2834
Symbol	bst/BSFA
Website	https://www.anipharmaceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.63%
EV Earnings	25.14x
EV/EBIT	22.51x
EV/EBITDA	11.32x
EV/Sales	2.35x
Forward P/E	9.29x
P/B ratio	3.24x
P/E ratio	21.61x
P/S ratio	1.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.42%
EBITDA Margin	20.31%
Gross margin	60.83%
Gross Profit	EUR 487.3M
Gross Profit Growth	40.47%
Gross Profit Growth Q	15.95%
Gross Profit Growth3 Y	36.32%
Gross Profit Growth5 Y	35.03%
Net Income	EUR 73.2M
Net Income Growth Q	88.08%
Pretax Margin	12.56%
Profit Margin	9.98%
Profit Per Employee	EUR 75,494
ROA	4.43
Roa5y	0.9
ROCE	8.14
ROE	18.32
Roe5y	-2.48
ROIC	8.78
Roic5y	2.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	6.04%
Cagr1y	15.46%
Cagr3y	27.07%
Cagr5y	17.58%
EPS Growth Q	86.72
Revenue Growth	37.04x
Revenue Growth Q	20.46x
Revenue Growth3 Y	37.07x
Revenue Growth5 Y	34.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.68
Assets	EUR 1.2B
Cash	EUR 282.8M
Current Assets	EUR 633.5M
Current Liabilities	EUR 203.1M
Debt	EUR 546.6M
Debt EBITDA	EUR 3.29
Debt Equity	EUR 1.12
Equity	EUR 487.7M
Interest Coverage	3.16
Liabilities	EUR 745.6M
Long Term Assets	EUR 599.8M
Long Term Liabilities	EUR 542.5M
Net Cash	EUR -263.8M
Net Cash By Market Cap	EUR -16.67
Net Debt EBITDA	EUR 1.62
Net Debt Equity	EUR 0.54
Tangible Book Value	EUR 28.3M
Tangible Book Value Per Share	EUR 1.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.12
Inventory Turnover	2.58
Net Working Capital	EUR 174.2M
Quick ratio	2.43
Working Capital	EUR 440.2M
Working Capital Turnover	EUR 1.9

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	79.81%
1Y total return	15.45%
200-day SMA	70.38
3Y total return	105.2%
50-day SMA	65.91
50-day SMA vs 200-day SMA	50under200
5Y total return	124.68%
All Time High	84
All Time High Change	-15.48%
All Time High Date	2025-10-27
All Time Low	4.36
All Time Low Change	1,527.69%
All Time Low Date	2013-08-09
ATR	2.38
Ch YTD	4.41
High	76.5
High52	84
High52 Date	2025-10-27
High52ch	-16.67%
Low	69.5
Low52	49.6
Low52 Date	2025-05-23
Low52ch	41.13%
Ma50ch	7.72%
Price vs 200-day SMA	0.88%
RSI	57.19
RSI Monthly	58.07
RSI Weekly	54.31
Sharpe ratio	0.38x
Sortino ratio	0.83
Total Return	-11.1%
Tr YTD	4.41
Tr1m	4.41%
Tr1w	1.43%
Tr3m	2.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 83.5M
Operating Income Growth	560.7
Operating Income Growth Q	112.6
Operating Income Growth3 Y	70.56
Operating margin	10.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	21,073,305%
Shares Insiders	5.43%
Shares Institutions	98.75%
Shares Qo Q	-1.06%
Shares Yo Y	11.1%
Short Ratio	9.75

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	23x
Bv Per Share	23.32
Ch10y	79.81
Ch1m	4.41
Ch1w	1.43
Ch1y	15.45
Ch3m	2.9
Ch3y	105.2
Ch5y	124.7
Ch6m	-7.79
Change	-1.41%
Change From Open	-1.41
Close	71
Days Gap	0
Depreciation Amortization	77,486,979.6
Dollar Volume	21,000
Earnings Date	2026-05-08
EBIT	EUR 83.5M
EBITDA	EUR 162.7M
EPS	EUR 3.39
F Score	6
Fiscal Year End	December
Founded	2,001
Goodwill	52,980,665.8
Graham Number	39.65792
Graham Upside	-43.35
Income Tax	EUR 20.7M
Is Primary Listing	0
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Ma150	69.66
Ma150ch	1.92%
Ma20	68.03
Ma20ch	4.37%
Next Earnings Date	2026-08-07
Open	71
Position In Range	7.14
Ppne	56,910,969.6
Price Date	2026-05-08
Price EBITDA	EUR 9.72
Ptbv Ratio	55.86
Relative Volume	13.04x
Revenue	801,130,214x
Tax By Revenue	2.58x
Tax Rate	20.58%
Tr6m	-7.79%
Volume	300
Z Score	2.42

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BST/BSFA pay a dividend?

Capital-return profile for this ticker.

Performance

BST/BSFA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BST/BSFA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+98.8%

Share of float held by funds and institutions

Insider ownership

+5.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BST/BSFA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.2

Neutral momentum band

Price vs 200-day MA

+0.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BST/BSFA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bst/BSFA stock rating?

bst/BSFA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bst/BSFA analysis?

The full report lives at /stocks/bst/BSFA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bst/BSFA?

The latest report frames bst/BSFA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bst/BSFA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.